Advertisement

Purines pp 215-221 | Cite as

The Endogenously Formed Adenosine of the Brain: Its Status as a Regulatory Signal Appraised in Relation to Actions of Homocystein

  • Henry McIlwain
Part of the Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology book series (SSNIC)

Abstract

Adenosine is so readily formed in the brain that for some time its quantity there was overestimated by a factor of 20 or more (Berne et al. 1974; Newman and McIlwain, 1977). Now, rapid fixation methods applied to the brain and to isolated cerebral tissues adequately prepared and maintained, give values of some 1 nmole adenosine/g: about the concomitant quantity of cyclic AMP, and less than one thousandth that of the ATP. Numerous circumstances that increase the content or output of the adenosine of cerebral tissues have been observed and collated (Newman and McIlwain, 1977; Arch and Newsholme, 1978) and include ischemia, hypoxia, excitation, adrenaline, noradrenaline and glutamate. By contrast, few circumstances diminish the content or output.

Keywords

Regulatory Signal Cerebral Tissue Inhibitory Tone Excitatory Action Endogenous Adenosine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arch, J.R.S. and Newsholme, E.A. (1978) Essays in Biochem. 14, 82–123.Google Scholar
  2. Berne, R.M., Rubio, R. and Curnish, R.R. (1974). Circ. Res., 35, 262–271.CrossRefGoogle Scholar
  3. Broch, O.J. and Ueland, P.M. (19βU). J. Neurochem. 35, 484–488.Google Scholar
  4. Cannon, W.B. (1929). Physiol. Rev. 9, 399–431.Google Scholar
  5. Dewhurst, I.C., Hagan, J.J., Morris, R.G.M. and Griffiths, R. (1983). J. Neurochem. 40, 752–757.PubMedCrossRefGoogle Scholar
  6. Folbergrová, J. (1981). Neuroscience 6,•1405–1411.Google Scholar
  7. Fonlupt, P., Rey, C. and Pacheco, H. (1981). J. Neurochem. 36, 165–170.PubMedCrossRefGoogle Scholar
  8. Fox, I.H. and Kelley, W.N. (1978). Ann. Rev. Biochem. 47, 655–686.Google Scholar
  9. Fredholm, B.B. (1980). Trends in Pharmacol. Sci. 1, 129–132.Google Scholar
  10. Fredholm, B.B. and Hedqvist, P. (1980) Biochem. Pharmacol. 29, 1635–1643.PubMedCrossRefGoogle Scholar
  11. Kaeser, A.C., Rodnight, R. and Ellis, B.A. (1969). J. Neurol. Neurosurg. Psychiat., 32, 88–93.Google Scholar
  12. Mcllwain, H. (1952). Biochem. Soc. Sympos. 8, 27–43.Google Scholar
  13. Mcllwain, H. (1972). Biochem. Soc. Sympos. 36, 69–85.Google Scholar
  14. Mcllwain, H. and Bachelard, H.S. (1985). Biochemistry and the Central Nervous System. 5th edition, 600–609. Churchill Livingstone, London.Google Scholar
  15. Mcllwain, H. and Poll, J.D. (1983). Biochem. Soc. Bull. 5, (4), 33.Google Scholar
  16. Mcllwain, H. and Poll, J.D. (1984). Neurochem. Internat., in press.Google Scholar
  17. Montero, J.M. and Fes, J.B. (1982). J. Neurochem. 39, 982–989.PubMedCrossRefGoogle Scholar
  18. Mudd, S.H. and Levy, H.L. (1978). In The Metabolic Basis of Inherited Disease. (eds. J.B. Stanbury, J.B. Wygarden and D.S. Fredrickson), 458–503. McGraw Hill, New York.Google Scholar
  19. Newby, A.C. (1984) Trends in Biochem. Sci. 9, 42–44.Google Scholar
  20. Newman, M. and Mcllwain, H. (1977). Biochem. J., 164, 131–137.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Phillis, J.W., Kostopoulos, G.K., and Limacher, J.J. (1975). Europ. J. Pharmacol. 30, 125–129.CrossRefGoogle Scholar
  22. Rabe, C.S. and McGee, R. (1983). J. Neurochem. 41, 1623–1634.PubMedCrossRefGoogle Scholar
  23. Reddington, M. and Pusch, R. (1983). J. Neurochem. 40, 285–290.PubMedCrossRefGoogle Scholar
  24. Rubio, R. and Berne, R.M. (1975). In Blood Flow and Metabolism (eds. A.M. Harper et al.) Churchill Livingstone, Edinburgh.Google Scholar
  25. Schrader, J. (1983). In Regulatory Functions of Adenosine (eds. R.M. Berne, T.W. Rall and R. Rubio) 133–156. Nijhof, Boston.CrossRefGoogle Scholar
  26. Scholefield, C.N. (1978). Brit. J. Pharmacol. 63, 239–244.CrossRefGoogle Scholar
  27. Stone, T.W. (1981). Neuroscience 6, 523–555.PubMedCrossRefGoogle Scholar
  28. Stone, T.W. and Taylor, D.A. (1978). Brit. J. Pharmacol. 64, 369–374.CrossRefGoogle Scholar
  29. Ueland, P.M. and Saebo, J. (1979). Biochim. Biophys. Acta 587, 341–352.PubMedCrossRefGoogle Scholar
  30. Williams, M. (1984). In Handbook of Neurochemistry (ed. Lajtha, A.) 6, 1–26. Plenum, New York.CrossRefGoogle Scholar
  31. Wuerthele, S.E., Yasuda, R.P., Freed, W.J. and Hoffer, B.J. (1982). Life Sci. 31, 2683–2692.PubMedCrossRefGoogle Scholar

Copyright information

© The Contributors 1985

Authors and Affiliations

  • Henry McIlwain

There are no affiliations available

Personalised recommendations